| US 7,592,355 B2 | ||
| Quinolinone-carboxamide compounds as 5-HT, receptor agonists | ||
| Daniel Marquess, Half Moon Bay, Calif. (US); Paul R. Fatheree, San Francisco, Calif. (US); S. Derek Turner, San Francisco, Calif. (US); and Daniel D. Long, San Francisco, Calif. (US) | ||
| Assigned to Theravance, Inc., South San Francisco, Calif. (US) | ||
| Filed on Jun. 29, 2007, as Appl. No. 11/824,450. | ||
| Application 11/824450 is a continuation of application No. 11/100113, filed on Apr. 06, 2005, granted, now 7,375,114. | ||
| Claims priority of provisional application 60/560076, filed on Apr. 07, 2004. | ||
| Prior Publication US 2007/0270457 A1, Nov. 22, 2007 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. C07D 451/02 (2006.01); A61K 31/46 (2006.01); A61P 1/10 (2006.01) | ||
| U.S. Cl. 514—304 [546/124; 546/126] | 20 Claims |
1. A compound of the formula
 or a pharmaceutically-acceptable salt thereof.
|